EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Early renal injury in children and adolescents with type 1 versus type 2 diabetes mellitus: a comparative narrative review

Ashraf T. Soliman, Fawzia Alyafei, Nada Alaaraj, Noor Hamed, Shayma Mohamed, Ahmed Elawwa

Childhood Kidney Diseases · 2026-10-01 · 30 (3) · 185-197

DOI: 10.3339/ckd.26.027 ↗
AbstractBibliografische Angaben

Abstract

Diabetic kidney disease is a major long-term complication of diabetes, with renal injury potentially beginning during childhood or adolescence. This narrative review compares the prevalence, onset, and progression of early renal abnormalities in youth-onset type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and summarizes underlying mechanisms and renoprotective strategies. Thirty-nine PubMed-indexed publications met the inclusion criteria. Compared with T1DM, youth-onset T2DM was associated with earlier and more frequent albuminuria, approximately threefold higher hypertension prevalence by early adulthood, earlier hyperfiltration, and nearly twice the cumulative burden of overt diabetic kidney disease by the third decade of life. In T1DM, renal injury is driven mainly by hyperglycemia-related hemodynamic and tubuloglomerular disturbances, whereas in T2DM it is amplified by insulin resistance, visceral adiposity, dyslipidemia, hyperuricemia, and inflammation. Renoprotective strategies include intensive glycemic control, renin-angiotensin system blockade, sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and metabolic interventions. Early surveillance for albuminuria, hypertension, and hyperfiltration is warranted in both groups, with particular urgency in youth-onset T2DM.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →